Without this knowledge, identifying sites of TXNIP activity in relation to neuropathology, identifying the neuroanatomical distribution and cell types mediating TXNIP activity in particular, will hinder progress on developing TXNIP as a therapeutic target for brain diseases. Here, TXNIP is linked to brain disorder.